New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil

Renin–angiotensin–system (RAS) activation plays a key role in the development of hypertension and cardiovascular disease. Drugs that antagonize the RAS (angiotensin-converting enzyme [ACE] inhibitors and angiotensin receptor blockers [ARBs]) have proven clinical efficacy in reducing blood pressure v...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpe, Massimo, Savoia, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308687/
https://www.ncbi.nlm.nih.gov/pubmed/22457601
http://dx.doi.org/10.2147/IBPC.S13784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308687/
https://www.ncbi.nlm.nih.gov/pubmed/22457601
http://dx.doi.org/10.2147/IBPC.S13784

Ejemplares similares